课题基金 / 基金详情

Characterizing cognition across the lifespan in untreated psychosis in China

Characterizing cognition across the lifespan in untreated psychosis in China
描述中国未经治疗的精神病患者整个生命周期的认知特征
批准号:
9403816
负责人:
MATCHERI S. KESHAVAN
金额:
$60.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2020-05-31

项目摘要

项目成果

MATCHERI S. KESHAVAN的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):我们建议利用一个独特的机会,在一个不太可能继续存在的伦理适当的背景下,在一个未经治疗的大样本精神病患者(IWP)中研究认知及其与其他领域的关系。在精神病发作后,对接受治疗的IWP的认知研究表明,许多SCZ患者存在持续性缺陷;这些缺陷存在于双相情感性精神病中,程度稍轻,表明精神病的严重程度持续存在。为了解决这一问题,我们建议在宁夏对完全未经治疗的IWP进行大样本(n=500)的认知研究,这些样本在AP治疗之前进行评估,他们的年龄范围很广(21到65岁),并且是社区样本。宁夏是中国最贫穷和最偏远的省份之一,686计划还没有完全渗透到那里,但未经治疗的病例正在增加。还将招募接受治疗的IWP(n=500)的社区抽样对照组(在地点、性别、年龄和病程上匹配)。我们的目标是阐明在没有药物作用的情况下,认知的自然过程及其与症状和功能的关系。在686国民待遇计划中,我们拥有前所未有的机会做到这一点。我们的多学科研究团队由来自流行病学、临床心理学和精神病学领域的世界公认的专家组成。在成功合作的历史基础上,每个调查员都带来了丰富的能力建设经验,以执行这一具有挑战性的项目。一个主要目标也是在宁夏培训一批新的调查人员,以提高干预未经治疗的精神病的能力,从而成为686项目扩大规模的典范。
英文摘要
 DESCRIPTION (provided by applicant): We propose to take advantage of a unique opportunity to study cognition and its relation to other domains in a large untreated sample of individuals with psychosis (IWP), within an ethically appropriate context that is unlikely to continue to be available. After the onset of psychosis, studies of cognition in treated IWP suggest persisting deficits in many SCZ patients; these are present in bipolar affective psychoses to a somewhat lesser extent, indicating a continuum of severity in psychosis. To address this, we propose to study cognition among a large sample (n=500) of completely untreated IWP, assessed prior to AP treatment, within Ningxia Province who span a wide age range (21 to 65) and are community sampled. Ningxia is among the most poor and remote provinces in China, where the 686 Program has not fully penetrated but where identification of untreated cases is increasing. A community sampled comparison group of treated IWP's (n=500) (matched on locale, gender, age, and duration of illness) will also be recruited. Our goal is to illuminate the natural course of cognition and its relation to symptoms and functioning, in the absence of medication effects. We possess an unprecedented opportunity to do so within the 686 national treatment program. Our multidisciplinary research team is comprised of world-recognized experts from the fields of epidemiology, clinical psychology, and psychiatry. Building upon a history of successful collaborations, each investigator brings extensive capacity-building experience to execute this challenging project. A major goal is also to train a new cohort of investigators in Ningxia Province to increase capacity to intervene with untreated psychosis, thus serving as a model for scale-up for the 686 program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
Longitudinal trajectories in treated and untreated schizophrenia
  • 批准号:
    10306962
  • 项目类别:
  • 资助金额:
    $64.17万
  • 财政年份:
    2021
  • 负责人:
    MATCHERI S. KESHAVAN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: